Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Mirum Pharmaceuticals (MIRM) Return on Capital Employed: 2020-2025

Historic Return on Capital Employed for Mirum Pharmaceuticals (MIRM) over the last 5 years, with Sep 2025 value amounting to -0.07%.

  • Mirum Pharmaceuticals' Return on Capital Employed rose 10.00% to -0.07% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.07%, marking a year-over-year increase of 10.00%. This contributed to the annual value of -0.16% for FY2024, which is 10.00% up from last year.
  • Latest data reveals that Mirum Pharmaceuticals reported Return on Capital Employed of -0.07% as of Q3 2025, which was up 30.70% from -0.10% recorded in Q2 2025.
  • Mirum Pharmaceuticals' 5-year Return on Capital Employed high stood at -0.07% for Q3 2025, and its period low was -0.86% during Q3 2021.
  • Its 3-year average for Return on Capital Employed is -0.21%, with a median of -0.19% in 2023.
  • Per our database at Business Quant, Mirum Pharmaceuticals' Return on Capital Employed declined by 18bps in 2021 and then skyrocketed by 35bps in 2022.
  • Mirum Pharmaceuticals' Return on Capital Employed (Quarterly) stood at -0.78% in 2021, then surged by 33bps to -0.45% in 2022, then rose by 25bps to -0.19% in 2023, then climbed by 3bps to -0.16% in 2024, then rose by 10bps to -0.07% in 2025.
  • Its Return on Capital Employed was -0.07% in Q3 2025, compared to -0.10% in Q2 2025 and -0.14% in Q1 2025.